Skip to main content

Tessa M. Andermann

Tessa Andermann, MD, MPH, is a UNC Lineberger member who focuses on the care of immunocompromised patients with cancer. Her research is focused on the impact of the intestinal microbiome on cancer outcomes.

MD, MPH
Assistant Professor, Infectious Diseases
Department of Medicine
UNC-Chapel Hill
Clinical Research

Area of Interest

As an Assistant Professor of Medicine in the Division of Infectious Diseases at UNC-Chapel Hill, Tessa Andermann, MD, MPH, focuses on the care of immunocompromised patients with cancer. Her multi-disciplinary research is primarily focused on investigating the impact of the intestinal microbiome on cancer outcomes with the ultimate goal of developing microbiome-targeted therapies for the prevention and treatment of infectious diseases in immunocompromised patient populations.

Her current projects include:

  1. Investigating the role of the gut antimicrobial “resistome” in the development of bloodstream and other infections with multi-drug-resistant organisms in patients with hematologic malignancies.
  2. Developing microbial predictors of therapeutic efficacy and therapy-related gastrointestinal complications following administration of cellular and other immunotherapies in patients with cancer.
  3. Using the intestinal microbiome as a tool to inform antimicrobial stewardship in immunocompromised patients.

Awards and Honors

  • UNC School of Medicine Physician Scientist Training Award, 2020
  • Amy Strelzer Manasevit Foundation Award, 2019
  • NIH-NCATS KL2 Mentored Career Award, 2017
  • ASBMT New Investigator’s Award, 2017

Find publications on PubMed

No profile image on file